Compare HCA Health Inc (HCA) vs Icl Group Ltd (ICL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Icl Group Ltd — how do they compare? HCA Health Inc trades at $373.29 (market cap $82.17B), while Icl Group Ltd trades at $5.01 (market cap $6.65B). The key difference: HCA Health Inc is far larger — about 12.4× Icl Group Ltd's market cap, and Icl Group Ltd pays the higher dividend (3.77%). Which is the better fit depends on your goals.
| HCA | ICL | |
|---|---|---|
Market Cap | $82.17B | $6.65B |
Sector | Health | Basic Materials |
52-Week High | $545.13 | $7.03 |
52-Week Low | $334.32 | $4.80 |
Enterprise Value | $131.08B | $9.22B |
Dividend Yield | 0.84% | 3.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $373.09, up 0.51% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 preliminary revenue above expectations but cut full-year profit guidance, causing recent stock pressure. Analyst consensus remains bullish with a $469.40 price target, though multiple law firms are investigating potential securities law violations following the guidance revision.
Investment outlook balances strong operational performance against near-term headwinds. The stock offers value with a 12.76 P/E ratio and consistent earnings beats, but faces risks from rising expenses, payer mix challenges, and ongoing legal investigations. Institutional sentiment remains positive despite technical weakness and recent guidance concerns.
ICL trades at $5.25, up 3.96% today, with neutral technical signals and mixed earnings history. The company maintains stable cash flow and recently completed an $800 million senior notes offering. Valuation metrics show a P/E of 24.05 and P/S of 0.88, while profitability margins remain modest. All four covering analysts rate the stock as Hold.
Outlook is cautious due to flat analyst sentiment and declining profit margins, though operational cash flow supports dividend payments. Key risks include raw material costs and foreign exchange volatility. The stock offers income via dividends but lacks near-term growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Icl Group Ltd
ICL Group Ltd is a manufacturer of products based on minerals. The firm is comprised of four segments: phosphate solutions, potash, industrial products, and innovative agriculture solutions (IAS). These segments all contribute to the company's development of agriculture, food, and engineered material products and services. The company mines and manufactures potash and phosphates to be used as ingredients in fertilizers and serve as a component in the pharmaceutical and food additives industries. It is also engaged in industrial additives and materials, including flame retardants, phosphate salts, specialty phosphate blends, purified phosphoric acid, electronic-grade specialty phosphoric acids. Its geographical segments are Europe, Asia, North & South America, and the Rest of the world.
Read more on ICL →
